{"id":108666,"date":"2021-05-26T11:07:02","date_gmt":"2021-05-26T11:07:02","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108666"},"modified":"2021-05-26T11:07:02","modified_gmt":"2021-05-26T11:07:02","slug":"congenital-fiber-type-disproportion","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/","title":{"rendered":"Congenital fiber type disproportion"},"content":{"rendered":"<p>Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-108666","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Congenital fiber type disproportion - Definition of Congenital fiber type disproportion<\/title>\n<meta name=\"description\" content=\"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Congenital fiber type disproportion - Definition of Congenital fiber type disproportion\" \/>\n<meta property=\"og:description\" content=\"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-26T11:07:02+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/\",\"name\":\"Congenital fiber type disproportion - Definition of Congenital fiber type disproportion\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-26T11:07:02+00:00\",\"dateModified\":\"2021-05-26T11:07:02+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Congenital fiber type disproportion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Congenital fiber type disproportion - Definition of Congenital fiber type disproportion","description":"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/","og_locale":"en_US","og_type":"article","og_title":"Congenital fiber type disproportion - Definition of Congenital fiber type disproportion","og_description":"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/","og_site_name":"Glossary","article_published_time":"2021-05-26T11:07:02+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/","name":"Congenital fiber type disproportion - Definition of Congenital fiber type disproportion","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-26T11:07:02+00:00","dateModified":"2021-05-26T11:07:02+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Congenital fiber type disproportion (CFTD) is a rare muscle disease, specifically Type I muscle fibers. It is characterized by scoliosis, loss of muscle tone, short stature, dislocated hips, and foot deformities, all of which are evident at birth. Although CFTD is present at birth, symptoms tend to improve with age. Some cases of CFTD are thought to occur sporadically. Familial transmission also has been evidenced, and in some cases, gene mutations have been identified in genes that encode for muscle proteins. Over all, research presents a rather heterogeneous etiology for CFTD and incidence rates are unknown.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/congenital-fiber-type-disproportion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Congenital fiber type disproportion"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108666"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108666\/revisions"}],"predecessor-version":[{"id":108667,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108666\/revisions\/108667"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}